Comment
doi: 10.1200/JCO.2014.58.5299.
Epub 2014 Nov 10.
Reply to D. Pouessel et al, J.B. Aragon-Ching, and B.A. Adesunloye
Affiliations
- PMID: 25385726
- DOI: 10.1200/JCO.2014.58.5299
Item in Clipboard
Comment
Reply to D. Pouessel et al, J.B. Aragon-Ching, and B.A. Adesunloye
J Clin Oncol.
.
No abstract available
Comment on
-
Everything old is new again! Neoadjuvant chemotherapy in the treatment of muscle-invasive bladder cancer.J Clin Oncol. 2014 Jun 20;32(18):1868-70. doi: 10.1200/JCO.2014.55.4055. Epub 2014 May 12. J Clin Oncol. 2014. PMID: 24821880 No abstract available.
-
Dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin neoadjuvant chemotherapy in bladder cancer: ready for prime time?J Clin Oncol. 2014 Dec 20;32(36):4168-9. doi: 10.1200/JCO.2014.58.0498. Epub 2014 Nov 10. J Clin Oncol. 2014. PMID: 25385728 No abstract available.
-
Neoadjuvant phase II studies of modified methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer.J Clin Oncol. 2014 Dec 20;32(36):4170. doi: 10.1200/JCO.2014.57.9318. Epub 2014 Nov 10. J Clin Oncol. 2014. PMID: 25385733 No abstract available.
-
Neoadjuvant chemotherapy for muscle-invasive bladder cancer: are we asking the right questions?J Clin Oncol. 2014 Dec 20;32(36):4169-70. doi: 10.1200/JCO.2014.57.3154. Epub 2014 Nov 10. J Clin Oncol. 2014. PMID: 25385734 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
